MarketBeat Deals and strategy
Drugs Made In America Acquisition II (DMII) Earnings Date and Reports 2026
Drugs Made In America Acquisition II (DMII) announced its Q2 2026 earnings on August 14, 2026, reporting an EPS of $0.07. The company currently has a trailing EPS of $0.00. Investors can sign up for alerts to stay updated on future earnings announcements and reports.